National Institute for Clinical Excellence (NICE) Issues Draft "No" for Pfizer Inc. (PFE)'s Xalkori, but Opens Consultation
3/27/2013 8:37:58 AM
More...
|
InterMune, Inc. (ITMN) Release: Esbriet® (pirfenidone) Receives Positive Final Appraisal Determination From National Institute for Clinical Excellence (NICE) for Idiopathic Pulmonary Fibrosis (IPF)
3/21/2013 10:27:03 AM
More...
|
National Institute for Clinical Excellence (NICE) U-Turn on Novartis AG (NVS)'s Xolair for Asthma
3/7/2013 8:34:56 AM
More...
|
Novartis AG (NVS)'s Jakavi Turned Down by National Institute for Clinical Excellence (NICE) for Blood Cancer
2/13/2013 7:24:42 AM
More...
|
UK's National Institute for Clinical Excellence (NICE) Rejects Genentech (RHHBY)'s Avastin for Ovarian Cancer
2/1/2013 6:58:12 AM
More...
|
UK's National Institute for Clinical Excellence (NICE) Offers Guidance Supporting Bioventus' EXOGEN Device
1/24/2013 9:04:18 AM
More...
|
Alimera Sciences (ALIM)' ILUVIEN® Receives Final Published Guidance From U.K.'s National Institute for Clinical Excellence (NICE)
1/23/2013 9:07:52 AM
More...
|
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE) Drug Wins National Institute for Clinical Excellence (NICE) Nod for Irregular Heartbeats
1/23/2013 7:26:13 AM
More...
|
National Institute for Clinical Excellence (NICE) Backs AF Blood Pressure Device
1/18/2013 7:43:52 AM
More...
|
National Institute for Clinical Excellence (NICE) Says "No" on Pfizer Inc. (PFE) Kidney Cancer Drug
12/7/2012 8:37:52 AM
More...
|
|